These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31152339)

  • 21. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity evaluation and the genotype-phenotype analysis of OPA1 variants.
    Xu X; Wang P; Jia X; Sun W; Li S; Xiao X; Hejtmancik JF; Zhang Q
    Mol Genet Genomics; 2021 Jul; 296(4):845-862. PubMed ID: 33884488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy.
    Almind GJ; Grønskov K; Milea D; Larsen M; Brøndum-Nielsen K; Ek J
    BMC Med Genet; 2011 Apr; 12():49. PubMed ID: 21457585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.
    Heiduschka P; Schnichels S; Fuhrmann N; Hofmeister S; Schraermeyer U; Wissinger B; Alavi MV
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1424-31. PubMed ID: 19834041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
    Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
    Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis.
    Han J; Li Y; You Y; Fan K; Lei B
    BMC Ophthalmol; 2022 Jul; 22(1):322. PubMed ID: 35883160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy.
    Nakamura M; Lin J; Ueno S; Asaoka R; Hirai T; Hotta Y; Miyake Y; Terasaki H
    Ophthalmology; 2006 Mar; 113(3):483-488.e1. PubMed ID: 16513463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy.
    Gallus GN; Cardaioli E; Rufa A; Da Pozzo P; Bianchi S; D'Eramo C; Collura M; Tumino M; Pavone L; Federico A
    Mol Vis; 2010 Feb; 16():178-83. PubMed ID: 20157369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy.
    Van Bergen NJ; Crowston JG; Kearns LS; Staffieri SE; Hewitt AW; Cohn AC; Mackey DA; Trounce IA
    PLoS One; 2011; 6(6):e21347. PubMed ID: 21731710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiethnic involvement in autosomal-dominant optic atrophy in Singapore.
    Loo JL; Singhal S; Rukmini AV; Tow S; Amati-Bonneau P; Procaccio V; Bonneau D; Gooley JJ; Reynier P; Ferré M; Milea D
    Eye (Lond); 2017 Mar; 31(3):475-480. PubMed ID: 27858935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal vessel diameters decrease with macular ganglion cell layer thickness in autosomal dominant optic atrophy and in healthy subjects.
    Rönnbäck C; Grønskov K; Larsen M
    Acta Ophthalmol; 2014 Nov; 92(7):670-4. PubMed ID: 24612963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
    Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Impairment Mechanisms of Novel OPA1 Mutations Predicted by Molecular Modeling in Patients With Autosomal Dominant Optic Atrophy and Auditory Neuropathy Spectrum Disorder.
    Namba K; Mutai H; Takiguchi Y; Yagi H; Okuyama T; Oba S; Yamagishi R; Kaneko H; Shintani T; Kaga K; Matsunaga T
    Otol Neurotol; 2016 Apr; 37(4):394-402. PubMed ID: 26905822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background.
    Pierron D; Ferré M; Rocher C; Chevrollier A; Murail P; Thoraval D; Amati-Bonneau P; Reynier P; Letellier T
    BMC Med Genet; 2009 Jul; 10():70. PubMed ID: 19619285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the
    García-López M; Jiménez-Vicente L; González-Jabardo R; Dorado H; Gómez-Manjón I; Martín MÁ; Ayuso C; Arenas J; Gallardo ME
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy.
    Alavi MV; Fuhrmann N; Nguyen HP; Yu-Wai-Man P; Heiduschka P; Chinnery PF; Wissinger B
    Exp Neurol; 2009 Dec; 220(2):404-9. PubMed ID: 19815013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic DNA testing and counselling for dominant optic atrophy due to a novel OPA1 mutation.
    Yoshida S; Yamaji Y; Yoshida A; Kuwahara R; Fujisawa K; Ishibashi T
    Can J Ophthalmol; 2006 Oct; 41(5):614-6. PubMed ID: 17016536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.
    White KE; Davies VJ; Hogan VE; Piechota MJ; Nichols PP; Turnbull DM; Votruba M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2567-71. PubMed ID: 19234344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.